Enhanced Perioperative Care for the Prevention of Colorectal Anastomotic Leakage (DOUBLE CHECK)

February 21, 2022 updated by: Freek Daams, Amsterdam UMC, location VUmc

Enhanced Perioperative Care for Improving Outcomes After Colorectal Resection by Implementation of Best Practice for the Prevention of Anastomotic Leakage - Double Check Study: Protocol for a Multicenter Open-label Trial

This multicenter open-label trial is designed to evaluate if the implementation of an enhanced peri-operative care protocol results in an optimal intraoperative condition of the patient and in a decrease in incidence of anastomotic leakage after colorectal resection as compared to current practice.

Study Overview

Detailed Description

Rationale Colorectal anastomotic leakage (CAL) remains a severe complication following surgery with a reported incidence of 3-19% worldwide. Recent research has identified several modifiable peri-operative CAL risk factors, suggesting that the intraoperative condition of the patient plays an important role in CAL development.

Objective To successfully implement an enhanced perioperative care protocol, focusing on optimizing the intraoperative condition of the patient to minimalize exposure to CAL risk factors. Secondly, to investigate whether implementation of this new guideline results in a better intraoperative condition and a decreased CAL rate as compared to current practice.

Study design An open-label multicenter design with historical cohort in nine participating hospitals.

Study population All adult patients that are scheduled for a colorectal resection with creation of a primary anastomosis.

Intervention An enhanced perioperative best practice protocol. The Double Check bundle exists out of interventions applicable without the introduction of new material to the operating room, on top of usual care. The protocol is based on the results of our previous large, multicenter, international observational cohort study (LekCheck study), systematic literature analyses, an inventory in current protocols on peri-operative care and expert opinion. Consensus is reached with colorectal surgeons from all participating centers. The final protocol was reviewed critically by experts in the field of colorectal surgery before implementation.

Comparison 1592 historical patients that were treated with standard practice (LekCheck study group). In addition the anastomotic leakage rates from the national registry of the period after the LekCheck study and before the start of the Double Check study will be used for comparison.

Endpoints Compliance to the study protocol, the patient's intraoperative condition and exposure to modifiable intraoperative risk factors, 30-day CAL and other postoperative complications according to Clavien-Dindo classification. Follow-up will be 90 days after colorectal resection.

Study Type

Interventional

Enrollment (Anticipated)

1600

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antwerpen, Belgium
        • UZA
    • Limburg
      • Helmond, Limburg, Netherlands
        • Elkerliek
      • Maastricht, Limburg, Netherlands
        • Maastricht UMC+
    • Noord Brabant
      • Den Bosch, Noord Brabant, Netherlands
        • Jeroen Bosch Ziekenhuis
      • Uden, Noord Brabant, Netherlands
        • Bernhoven
      • Veldhoven, Noord Brabant, Netherlands
        • Máxima Medisch Centrum
    • Noord Holland
      • Amsterdam, Noord Holland, Netherlands
        • Amsterdam UMC
      • Hoorn, Noord Holland, Netherlands
        • Dijklander ziekenhuis
    • Zeeland
      • Terneuzen, Zeeland, Netherlands
        • ZorgSaam

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 and above
  • Bowel (small intestine/colon/rectal) resection with creation of a primary anastomosis
  • Ability to give informed consent

Exclusion Criteria:

  • The need for emergency surgery
  • Scheduled operation concerning a reoperation for complications from recent surgery (within 3 months after the initial procedure).
  • The inability to read or understand informed consent material

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Double Check enhanced perioperative care protocol
Perioperative care according to a best practice protocol focussing on optimizing the intraoperative condition of the patient and thereby minimalize exposure to 6 known modifiable independent intraoperative risk factors: anemia, hypothermia, epidural anesthesia, vasopressor drug administration, incorrect antibiotic prophylaxis and hyperglycemia.
See arm/group description
No Intervention: Current practice
Perioperative care according to usual practice. Historical controls from the previously conducted LekCheck study will be used as replacement of a control arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of modifiable intraoperative CAL risk factors present during surgery as assessed by the DoubleCheck list
Time Frame: Intraoperative phase

The primary outcome of the study is the intraoperative condition of the patient measured by the number of modifiable intraoperative CAL risk factors present in the patient.

During the operation, the Double Check list will be completed.

The list exists of 6 risk factors of interest:

  • Anemia: haemoglobin level < 7,5 (women) or < 8.0 (men) mmol/L
  • Hypothermia: temperature <36 degrees Celcius
  • Hyperglycemia: glucose level >10 mmol/L
  • Ue of vasopressor drugs: yes
  • Epidural analgesia
  • Incorrect antibiotic prophylaxis: not administered within 15-60 minutes prior to incision

The number of risk factors present will be counted and a score of 0 to 6 will be given to each individual patient.

Intraoperative phase

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Colorectal anastomotic leakage (CAL)
Time Frame: 30 days after surgery
Defined as a grade B or C according to the ISREC classification
30 days after surgery
Postoperative complications
Time Frame: 30 days after surgery
Defined as any adverse event occurring in the postoperative period until 30 days after surgery and graded according to the Dindo-Clavien classification
30 days after surgery
Postoperative mortality
Time Frame: 30 days after surgery
Measured as rate of death at 30-day follow-up
30 days after surgery
Hospital Stay
Time Frame: 30 days after surgery
Length of hospital and intensive care unit stay
30 days after surgery
Readmission
Time Frame: 30 days after surgery
30-day readmission rate
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2021

Primary Completion (Anticipated)

September 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

January 20, 2022

First Submitted That Met QC Criteria

February 21, 2022

First Posted (Actual)

February 22, 2022

Study Record Updates

Last Update Posted (Actual)

February 22, 2022

Last Update Submitted That Met QC Criteria

February 21, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The datasets generated during and/or analysed during the current study are/will be available upon request from dr. F. Daams

IPD Sharing Time Frame

Upon request

IPD Sharing Access Criteria

Upon request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraoperative Awareness

Clinical Trials on Enhanced perioperative care protocol

3
Subscribe